1970). C. parvuim appears to be most effective with highly immunogenic tumours such as those induced by chemical carcinogens (Smith and Scott, 1972) and may delay or prevent their development altogether in mice treated with methylcholanthrene . The mode and route of administration appear critical, and the effect is easily overcome by a large tumour burden (Scott, 1974) .
The exact mechanism by which C. parvurn inhibits tumour growth remains to be resolved but it is reasonable to assume that this is related to a nonspecific stimulation of the immune system of the host. Several biological activities relating to the effect of C. parvurm on the immune system have been documented. There is a nine-fold increase in the phagocytic activity of the sinusoidal macrophages of liver and spleen accompanied by a 30000 increase in spleen Accepted 30 December 1975 weight [8] [9] [10] days after a single injection of these organisms (Halpern et al., 1964) . Surprisingly though, the thymus-dependent functions of mice are depressed, producing a prolonged survival of homograft, a reduction in delayed hypersensitivity reactions and a reduced graft versus host response (Scott, 1974) .
At the same time C. parvcum boosts the antibody response to a variety of antigens in those cases where T cell cooperation is not required (Howard, Christie and Scott, 1973) . Perhaps as a result of this effect the treated mice demonstrate enhanced resistance to a variety of infections (Adlam, Broughton anid Scott, 1972) . As a result of these established biological properties it is widely assumed that C. parvurm mediates its antitumour properties via the mononuclear phagocytic system (Scott, 1974) . Baum and Fisher (1972) The role of the macrophage in the host response to cancer has been repeatedly emphasized but there is a tendency in many quarters to downgrade the importance of this cell in relation to the T lymphocyte in most reviews on tumour immunology. However, the macrophage by its versatility must be considered important in the host response. The mature macrophage can take up and process antigen and in so doing activate the lymphocyte (Askonas and Rhodes, 1965) . The macrophage is also important as an effector cell, killing target tumour cells by surface contact (Keller and Jones, 1971 ). In addition there is evidence that the macrophage plays a role in controlling the development of enhancement phenomena (Haughton, 1971) . It is readily apparent therefore why an increase in the population of macrophages would be beneficial to the host and incidentally would explain many of the biological properties of C. parvumn already described. In addition to the quantitative response the cells produced may be qualitatively different, demonstrating many of the features of macrophages activated by other agents (Scott, 1974) .
Additional evidence that implicates the monocyte/macrophage precursor as the target cell for the effect of C. parvurm comes from the study of the effects of irradiation. Whole body irradiation of mice shortly before C. parvum injection, prevents the development of resistance to tumour challenge, whilst irradiation after treatment fails to abrogate the antitumour effect (Milas et al., 1974) . This would suggest that the relevant cell arose from radiosensitive (rapidly dividing) precursors, but the mature cell was radioresistant. These are precisely the characteristics of the monocyte/macrophage family of cells (Baum, 1974) . This is not the first description of the action of C. parvum on macrophage precursors. Wolmark and Fisher (1974) showed that C. parvum could stimulate colony production in tumour-bearing mice after the initial effect of the tumour on the bone marrow had waned. More recently, Dimitrov et al. (1975) Assuming that such is the case, it becomes worthwhile to explore this phenomenon in depth. The most effective antitumour regime might be that combination of dose and time interval which gives the most prolonged and most potent stimulation to the bone marrow. In addition, the active component of C. parvum could be detected by sub-fractionation of the bacterium and re-testing the resulting fractions in this system. Finally, and of perhaps key importance to the planning of therapy for human malignancies, it might be possible to determine the msost effective combination of C. parvum and cytotoxic drugs so that the two agents might work synergistically. Such a combination has already been demonstrated to be effective against both animal and human tumours (Currie and Bagshawe, 1970; Fisher et al., 1975; Israel and Edelstein, 1974) . This work was supported by a generous grant from Tenovus, Cardiff. We wish to gratefully acknowledge the help and advice of several members of Professor Lajtha's department at the Paterson Laboratories, University of Manchester. The bacterial strains used in these experiments were kindly provided by the Wellcome Research Laboratories.
